BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12049488)

  • 1. Protein binding predictions in infants.
    McNamara PJ; Alcorn J
    AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Drug Binding to Human Serum Albumin and Alpha One Acid Glycoprotein in Diseased and Age Patient Populations.
    McNamara PJ; Meiman D
    J Pharm Sci; 2019 Aug; 108(8):2737-2747. PubMed ID: 30905706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of binding to albumin and alpha 1-acid glycoprotein on the clearance of drugs by the liver.
    Meijer DK; Van der Sluijs P
    Pharm Weekbl Sci; 1987 Apr; 9(2):65-74. PubMed ID: 3295762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
    Meijer DK; van der Sluijs P
    Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
    Wanwimolruk S; Denton JR
    J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
    Essassi D; Zini R; Tillement JP
    J Pharm Sci; 1990 Jan; 79(1):9-13. PubMed ID: 2313585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on binding of drug to serum protein].
    Otagiri M
    Yakugaku Zasshi; 2009 Apr; 129(4):413-25. PubMed ID: 19336995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):40-3. PubMed ID: 14749548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.
    Sager G; Jaeger R; Little C
    Br J Clin Pharmacol; 1989 Feb; 27(2):229-34. PubMed ID: 2713217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for monitoring free drug levels.
    Levy RH; Moreland TA
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein binding.
    Graham RA; Lum BL; Cheeti S; Jin JY; Jorga K; Von Hoff DD; Rudin CM; Reddy JC; Low JA; Lorusso PM
    Clin Cancer Res; 2011 Apr; 17(8):2512-20. PubMed ID: 21300760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered plasma drug binding in cancer: role of alpha 1-acid glycoprotein and albumin.
    Jackson PR; Tucker GT; Woods HF
    Clin Pharmacol Ther; 1982 Sep; 32(3):295-302. PubMed ID: 7105620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of lopinavir to human alpha1-acid glycoprotein and serum albumin.
    Gulati A; Boudinot FD; Gerk PM
    Drug Metab Dispos; 2009 Aug; 37(8):1572-5. PubMed ID: 19439488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
    Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANS-drug interactions to AAG and HSA fluorescence and equilibrium dialysis studies.
    Essassi D; Zini R; Tillement JP
    Prog Clin Biol Res; 1989; 300():423-6. PubMed ID: 2780639
    [No Abstract]   [Full Text] [Related]  

  • 16. Human alpha-1-glycoprotein and its interactions with drugs.
    Israili ZH; Dayton PG
    Drug Metab Rev; 2001 May; 33(2):161-235. PubMed ID: 11495502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of prazosin to alpha 1-acid glycoprotein and albumin: effect of protein purity and concentrations.
    Sager G; Jaeger R; Little C
    Pharmacol Toxicol; 1989 Apr; 64(4):365-8. PubMed ID: 2748545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
    Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
    Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of bupivacaine after continuous epidural infusion in infants with and without biliary atresia.
    Meunier JF; Goujard E; Dubousset AM; Samii K; Mazoit JX
    Anesthesiology; 2001 Jul; 95(1):87-95. PubMed ID: 11465589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.